Insider · CIK 0001662170

Militello John

CIK 0001662170 Name as filed on the most recent filing

Filed as Militello John (30)

34 transaction lines · from 30 filings · filed 2023-02-22 to 2026-05-21 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

34 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-05-19 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 1,157, disposed Open Form 4 filing 0001140361-26-022445
2026-05-13 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 3,083, disposed Open Form 4 filing 0001140361-26-021305
2026-02-18 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 3,862, disposed Open Form 4 filing 0001140361-26-006330
2026-02-13 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 12,341, disposed Open Form 4 filing 0001140361-26-006045
2025-11-18 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 3,240, disposed Open Form 4 filing 0001140361-25-042857
2025-10-14 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 4 lines 114,581, disposed Open Form 4 filing 0001140361-25-038302
2025-08-19 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 1,082, disposed Open Form 4 filing 0001140361-25-032092
2025-08-18 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 2,142, disposed Open Form 4 filing 0001140361-25-032092
2025-08-14 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 21,263, disposed Open Form 4 filing 0001140361-25-031761
2025-05-20 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 2,301, disposed Open Form 4 filing 0001140361-25-020163
2025-05-16 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 4,276, disposed Open Form 4 filing 0001140361-25-019902
2025-04-22 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 5,139, disposed Open Form 4 filing 0001140361-25-015426
2025-02-21 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 28,957, disposed Open Form 4 filing 0001140361-25-005845
2025-01-23 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 9,300, disposed Open Form 4 filing 0001140361-25-002069
2024-11-21 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 15,978, disposed Open Form 4 filing 0001140361-24-047757
2024-10-31 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 15,245, disposed Open Form 4 filing 0001140361-24-045099
2024-08-16 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 19,688, disposed Open Form 4 filing 0001140361-24-037934
2024-07-22 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 18,688, disposed Open Form 4 filing 0001140361-24-034029
2024-05-16 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 25,195, disposed Open Form 4 filing 0001140361-24-026881
2024-04-22 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 19,051, disposed Open Form 4 filing 0001140361-24-021703
2024-03-21 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 69,979, disposed Open Form 4 filing 0001140361-24-015101
2024-02-29 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 298,450, disposed Open Form 4 filing 0001140361-24-011170
2024-02-16 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 96,615, disposed Open Form 4 filing 0001140361-24-008888
2024-01-22 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 17,356, disposed Open Form 4 filing 0001140361-24-003421
2023-10-20 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 9,623, disposed Open Form 4 filing 0001140361-23-049426
2023-08-17 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 4,394, disposed Open Form 4 filing 0001140361-23-040693
2023-07-20 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 10,906, disposed Open Form 4 filing 0001140361-23-035859
2023-05-17 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 5,237, disposed Open Form 4 filing 0001140361-23-025741
2023-04-21 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 43,678, disposed Open Form 4 filing 0001140361-23-020312
2023-02-17 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 20,509, disposed Open Form 4 filing 0001140361-23-049079
2023-02-17 S, Open-market sale Rocket Pharmaceuticals, Inc.RCKT 23,711, disposed Open Form 4 filing 0001140361-23-008103

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 34
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Militello John, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001662170

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.